Showing 2151-2160 of 7385 results for "".
Biosimilar Recommended; Saunders to Head New Pfizer/Allergan Organization
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-biosimilar-recommended-saunders-to-head-new-pfizer-allergan-organization/18825/An FDA committee has recommended Pfizer's Inflectra, biosimilar to infliximab, developed by Celltrion. Sunbelt Melanoma Trial finds no benefit for IFN in Phase III melanoma. Pfizer/Allergan provides details on structure of new organization and announces leadership, including President and COO BrentJuvederm Approved for Lips, CoolMini Applicator Cleared
https://practicaldermatology.com/topics/psoriasis/juvederm-approved-for-lips-coolmini-applicator-cleared/18828/In this edition, a look at Allergan's Juvederm Voluma XC approval for lips an Zeltiq's CoolMini applicator for treatment of the sub mental area. Plus, there's new data for secukinumab in psoriatic arthritis (PSA) and Kathleen Sebelius has joined the Board of Directors of Dermira.How To Protect Against Losing Assets In A Divorce
https://practicaldermatology.com/topics/practice-management/how-to-protect-against-losing-assets-in-a-divorce/21399/Tips for minimizing potential financial pain from a marital split.Natural Ingredients and Their Applications in Dermatology
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/natural-ingredients-and-their-applications-in-dermatology/22022/Understanding the role of natural ingredients in therapeutic regimens may help physicians to harness these agents for maximum effect.The Safety of New Systemics
https://practicaldermatology.com/issues/practicaldermatology-com-march-2025/the-safety-of-new-systemics/33159/Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, provides an overview of the safey of systemic therapies such as JAK inhibitors and other similar drugs, giving dermatologists a high-level look at what they need to help clinical decision-making.New AD Guidelines: A Paradigm Shift in AD Care
https://practicaldermatology.com/programs/practical-dermatology-atopic-dermatitis/new-ad-guidelines-a-paradigm-shift-in-ad-care/24024/Peter Lio, MD, reviews an updated model of clinical guidance in a rapidly changing healthcare environment.Locks and Crocs: Keep on your Socks
https://practicaldermatology.com/youngmd-connect/resident-resource-center/locks-and-crocs-keep-on-your-socks/23454/A 44-year-old man develops new-onset recurrent hair splinters in both feet from lined Crocs.Nitric Oxide-Releasing Cleanser for Plantar Warts
https://practicaldermatology.com/topics/clinical-case-reports/nitric-oxide-releasing-cleanser-plantar-warts/27121/The authors present a case study of a 12-year-old girl developed a few small warts on the plantar surface of both feet, and over a 6-month period.Evaluating GEP Test Options
https://practicaldermatology.com/programs/practical-dermatology/evaluating-gep-test-options/35600/David Cotter, MD, a board-certified dermatologist, discusses what he looks for in a gene expression profile (GEP) test, including the types of clinical evidence that are most important.Buying a Laser, Circa 2024
https://practicaldermatology.com/issues/april-2024/buying-a-laser-circa-2024/24439/Joel Schlessinger, MD, shares his experiences with the process of adding new equipment to his dermatology practice, culminating in the purchase of the Sciton mJoule and JouleX lasers. He also highlights the importance of planning early for tax deductions and emphasizes the value of a supportive netw